The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein

Biochemical Journal

Volumn 352, Issue 2, 2000, Pages 583-591

  Glineur, C ^a   Davioud Charvet, E ^a   Vandenbunder, B ^a  

^a UNIV LILLE   (France)

Author keywords

NF B; Oxidative stress; Thioredoxin; Thioredoxin reductase

Indexed keywords

AMINO ACID; ASPARTIC ACID; CYSTEINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; N ETHYLMALEIMIDE; NITROBENZENE DERIVATIVE; SERINE; THIOREDOXIN; TRANSCRIPTION FACTOR REL;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHEMICAL BOND; CHEMICAL MODIFICATION; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSFECTION; MUTAGENESIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0034533176     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3520583     Document Type: Article

References (50)

1. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62
2. Oxidoreductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin
3. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro
4. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro
5. Redox regulation of fos and jun DNA-binding activity in vitro
6. Human transcription factor IIIC (TFttlC). Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding
7. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes
8. DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein
9. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro
10. NF-κB: Ten years after
11. Rel/NF-κB/lκB family: Intimate tales of association and dissociation
12. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor
13. Function and activation of NF-κB in the immune system
14. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells
15. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-κB p50 and p65
16. Role of cysteine 62 in DNA recognition by the p50 subunit of NF-κB
17. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB
18. Thioredoxin and glutarodoxin systems
19. Thioredoxin reductase
20. Thioredoxin redox control of cell growth and death and the effects of inhibitors
21. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF-κB
22. Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds
23. 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductese. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity
24. Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity
25. 2+ signals
26. Redox ragulation of a src family protein tyrosine kinase p56 Lck in T cells
27. Activation of NR-κB in vivo is regulated by multiple phosphorylations
28. Identilication of a new serine kinase that activates NF-κB by direct phosphorylation
29. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB
30. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism
31. Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit
32. A protein kinase-A recognition sequence is structurally linked to transformation by p59 v-Rel and cytoplasmic retention of p68 c-Rel
33. Identification of complex formation between two intracellular tyrosine kinase substrates: Human c-Rel and the p105 precursor of p5O NF-κB
34. Protein phosphatase X interacts with c-Rel and stimulates c-Rel/nuclear factor κB activity
35. Dkadaic acid: A new probe for the study of cellular regulation
36. Induction of nuclear factor-κB and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphotases 1 and 2A
37. Generation of small fusion genes carrying phleomycin resitance and Drosophila alcohol dehydrogenase reporter properties: Their application in retrovital vectors
38. Inhibition of nuclear factor κB by direct modification in whole cells - Mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers
39. Distinct effects of glutathione disulphide on the nuclear transcription factor κB and the activator protein-1
40. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism
41. Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells
42. Protein damage and degradation by oxygen radicals. IV. Oegradation of denatured protein
43. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
44. Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity
45. Interleukin-1 induced nuclear factor κB activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line
46. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes. Evidence for covalent modification of the p50 subunit
47. The mouse c-Rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain
48. Differences in κB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of lhe Rel protein
49. Stimulation of tyrosine-specific protein phosphorylation in the rat liver plasma membrane by oxygen radicals
50. Control of apoptosis by Rel/NF-κB transcription factors